Suppr超能文献

具有改变的秋水仙酰胺结合亲和力的中国仓鼠卵巢(CHO)细胞突变体。

Mutants of Chinese hamster ovary (CHO) cells with altered colcemid-binding affinity.

作者信息

Ling V, Aubin J E, Chase A, Sarangi F

出版信息

Cell. 1979 Oct;18(2):423-30. doi: 10.1016/0092-8674(79)90061-8.

Abstract

Clones of CHO cells stably resistant to colcemid have been isolated in the presence of the nonionic detergent Tween 80 after mutagen treatment. Successive single-step selections for increasing resistance were performed resulting in lines after three selection steps about 10 fold more resistant to colcemid than the parental cells. Three observations indicate that these colcemid-resistant (CMR) mutants are different from the colchicine-resistant permeability mutants isolated previously. First, their relative resistance to colcemid was not diminished in the presence of detergent which promoted increased drug permeability. Second, the CMR clones displayed limited cross-resistances only to tubulin-binding compounds. Third, the binding affinity of labeled colcemid by cytoplasmic extracts from CMR clones was reduced, and the reduction was greater in the more resistant clones. No reduction in binding of labeled colcemid was observed in the membrane-altered colchicine-resistant mutants. All these observations are consistent with the CMR clones being tubulin-altered mutants. In further support of this conclusion, we observed that tubulin purified from a CMR mutant still possessed reduced colcemid-binding affinity compared with that from parental cells.

摘要

经诱变处理后,在非离子去污剂吐温80存在的情况下,已分离出对秋水仙酰胺具有稳定抗性的中国仓鼠卵巢(CHO)细胞克隆。对提高抗性进行了连续的单步选择,经过三个选择步骤后得到的细胞系对秋水仙酰胺的抗性比亲代细胞高约10倍。三项观察结果表明,这些抗秋水仙酰胺(CMR)突变体与先前分离出的抗秋水仙素通透性突变体不同。第一,在促进药物通透性增加的去污剂存在下,它们对秋水仙酰胺的相对抗性并未降低。第二,CMR克隆仅对微管蛋白结合化合物表现出有限的交叉抗性。第三,CMR克隆的细胞质提取物对标记秋水仙酰胺的结合亲和力降低,且抗性越强的克隆降低幅度越大。在膜改变的抗秋水仙素突变体中未观察到标记秋水仙酰胺结合的减少。所有这些观察结果都与CMR克隆是微管蛋白改变的突变体一致。为进一步支持这一结论,我们观察到,与亲代细胞相比,从CMR突变体中纯化的微管蛋白对秋水仙酰胺的结合亲和力仍然降低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验